ORLANDO, Florida, April 4, 2011 /PRNewswire-FirstCall/ --
- Health Engagement Program to use MEDai's Risk Navigator as Tool in Coordinating Care Delivery
AtlantiCare, the largest health system in southeastern New Jersey, will allow its healthcare providers to better manage patient populations and track clinical and financial objectives with quality-focused tools from Elsevier/MEDai, a leading provider of predictive analytic solutions.
AtlantiCare's vision is to build healthy communities. It will use MEDai's Risk Navigator solutions to provide analytics for its Health Engagement program, which is positioned to prevent injury and illness, and manage health risks, chronic illnesses and healthcare utilization. Additionally, AtlantiCare is part of Premier, a collaborative to design and implement an Accountable Care Organization (ACO) in New Jersey. ACOs are designed to keep patients healthy and out of intensive care settings, while simultaneously shifting reimbursements to be based on quality outcomes and efficiencies.
AtlantiCare will use MEDai's Risk Navigator solutions in conjunction with its patient-centered medical home model to enhance cooperation and communication between plan, provider and nurse case managers. Risk Navigator provides the ability to integrate data from multiple sources and systems and produce information that is needed to provide proactive patient care.
"The collaborative nature of ACOs is an extremely important step in the evolution of our nation's healthcare systems," said Clayton Ramsey, COO, MEDai. "MEDai's predictive analytics and healthcare expertise aid clients in ensuring they have the necessary resources to make quality, efficient patient-care decisions based on accurate information."
For more than a decade, MEDai's predictive modeling suite has accurately forecasted prospective high-risk patients to improve patients' health and quality of care while controlling cost. Risk Navigator Clinical is built to fit the clinical workflow by wrapping business intelligence around a member-centric database providing evidence-based medicine guideline compliance information and cost and utilization forecasts. Clients can also leverage MEDai's motivation index to determine the level of member engagement most appropriate based on the members' motivation to self manage their conditions.
MEDai, Inc. is a subsidiary of Elsevier, a world-leading publisher of more than 2,000 scientific, technical and medical information products and services. MEDai offers award-winning solutions for the improvement of healthcare delivery. Utilizing cutting-edge technology, payors and care management organizations are able to predict patients at risk, identify cost drivers for their high-risk population, forecast future health plan costs, evaluate patient patterns over time and improve outcomes. For more information on MEDai, visit http://www.medai.com.
Elsevier is a world-leading publisher of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including The Lancet (http://www.thelancet.com) and Cell (http://www.cell.com), and close to 20,000 book titles, including major reference works from Mosby and Saunders. Elsevier's online solutions include SciVerse ScienceDirect (http://www.sciencedirect.com), SciVerse Scopus (http://www.scopus.com), Reaxys (http://www.reaxys.com), MD Consult (http://www.mdconsult.com) and Nursing Consult (http://www.nursingconsult.com ), which enhance the productivity of science and health professionals, and the SciVal suite (http://www.scival.com) and MEDai's Pinpoint Review (http://www.medai.com), which help research and health care institutions deliver better outcomes more cost-effectively.
A global business headquartered in Amsterdam, Elsevier ( http://www.elsevier.com) employs 7,000 people worldwide. The company is part of Reed Elsevier Group PLC (http://www.reedelsevier.com), a world-leading publisher and information provider, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).
Media Contact Tom Reller Vice President of Global Relations, Elsevier +1-212-462-1912 [email protected]